What is BioLineRx Ltd (BLRX) stock price today?

BioLineRx Ltd (BLRX) currently trades at $2.79 per share. The stock has a market capitalization of $10.21M and a P/E ratio of 0.00x.

Is BLRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, BioLineRx Ltd has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is BioLineRx Ltd's revenue and earnings?

BioLineRx Ltd has trailing twelve-month (TTM) revenue of $1.18M with profit margins of -99.60%. Earnings per share (EPS) is $0.00.

BLRX

BioLineRx Ltd

NASDAQ: BLRX · HEALTHCARE · BIOTECHNOLOGY

$2.79

-9.12% today

Updated 2026-04-30

Market cap

$10.21M

P/E ratio

0.00

P/S ratio

8.66x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$2 – $8

Volume

0.0M

Market cap

$10.21M

P/E ratio

0.00

P/S ratio

8.66x

EPS (TTM)

$0.00

Dividend yield

—

52W range

$2 – $8

Volume

0.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.0

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$17.50

+527.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -99.60%

- Negative free cash flow $-3.25M

- Revenue declining -98.30% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$4.80M	$28.94M	$1.19M	$1.18M
Net income	$-24.95M	$-60.61M	$-9.22M	$-1.18M	$-1.39M
EPS	—	—	—	—	$0.00
Free cash flow	$-26.56M	$-22.91M	$-43.93M	$-8.16M	$-3.25M
Profit margin	—	-1,262.79%	-31.86%	-99.58%	-99.60%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BLRX	$10.21M	31	3.7	2.0	6.7	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

BioLineRx Ltd trades at $2.79. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $1.18M. with profit margins at -99.60%.

Frequently asked questions

What is BioLineRx Ltd's stock price?

BioLineRx Ltd (BLRX) trades at $2.79.

Is BioLineRx Ltd overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of BioLineRx Ltd (BLRX)?

The analyst target price is $17.50, representing +527.2% upside from the current price of $2.79.

What is BioLineRx Ltd's revenue?

TTM revenue is $1.18M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio8.66x

ROE-11.00%

Beta0.48

50D MA$2.55

200D MA$3.30

Shares out0.00B

Float2.50B

Short ratio—

Avg volume0.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BLRX vs LLY →BLRX vs JNJ →BLRX vs ABBV →Stock screener →